Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SIRT2 | Q8IXJ6 | 15/20 | 0.51 |
| ▸ | NMBR | P28336 | 1/20 | 0.41 |
| ▸ | LTA4H | P09960 | 1/20 | 0.38 |
| ▸ | CPB1 | P15086 | 3/20 | 0.36 |
| ▸ | CPB2 | Q96IY4 | 3/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17859348 | 1.00 | SIRT2 (0.51) | SIRT2NMBRLTA4HCPB1CPB2 | |
| SCHEMBL29823742 | 0.89 | SIRT2 (0.47) | SIRT2NMBRCPB1CPB2 | |
| SCHEMBL523065 | 0.88 | SIRT2 (0.60) | SIRT2NMBRCPB1CPB2 | |
| SCHEMBL10026712 | 0.88 | SIRT2 (0.60) | SIRT2NMBRCPB1CPB2 | |
| SCHEMBL522051 | 0.88 | SIRT2 (0.60) | SIRT2NMBRCPB1CPB2 | |
| Hydrochloric Acid SCHEMBL522050 | 0.87 | SIRT2 (0.59) | SIRT2NMBRCPB1CPB2 | |
| Hydrochloric Acid SCHEMBL523064 | 0.87 | SIRT2 (0.59) | SIRT2NMBRCPB1CPB2 | |
| Hydrochloric Acid SCHEMBL522052 | 0.87 | SIRT2 (0.59) | SIRT2NMBRCPB1CPB2 | |
| SCHEMBL21690129 | 0.84 | SIRT2 (0.49) | SIRT2CPB1CPB2 | |
| SCHEMBL6773700 | 0.84 | SIRT2 (0.49) | SIRT2CPB1CPB2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240209020-A1 | REACTION AGENT FOR AMIDE REACTION AND METHOD FOR PRODUCING AMIDE COMPOUND USING SAME | CHUBU UNIVERSITY EDUCATIONAL FOUNDATION (JP) | 2024-06-27 | — | — | US | disclosed |
| EP-3786151-B1 | METHOD FOR PRODUCING AMIDE COMPOUND | CHUBU UNIV EDUCATIONAL FOUNDATION (JP) | 2023-06-07 | — | — | EP | disclosed |
| US-11512108-B2 | Method for producing amide compound | CHUBU UNIVERSITY EDUCATIONAL FOUNDATION (JP) | 2022-11-29 | — | — | US | disclosed |
| EP-4053101-A1 | REACTION AGENT FOR AMIDE REACTION AND METHOD FOR PRODUCING AMIDE COMPOUND USING SAME | Chubu University Educational Foundation (JP) | 2022-09-07 | — | — | EP | disclosed |
| US-20140271465-A1 | MATRIX METALLOPROTEASE (MMP) TARGETED AGENTS FOR IMAGING AND THERAPY | MALLINCKRODT LLC (US) | 2014-09-18 | — | — | US | disclosed |
| EP-0920307-A2 | DERIVATES FROM BISARYLTETRACARBONACID, AND PHARMARCEUTICAL PRODUCT CONTAINING THEM | Roche Diagnostics GmbH (DE) | 1999-06-09 | — | — | EP | disclosed |
| WO-1998006386-A2 | DERIVATES FROM BISARYLTETRACARBONACID, AND PHARMARCEUTICAL PRODUCT CONTAINING THEM | ROCHE DIAGNOSTICS GMBH (DE) | 1998-02-19 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140271465-A1 | MATRIX METALLOPROTEASE (MMP) TARGETED AGENTS FOR IMAGING AND THERAPY | MMP3, MMP26, MMP10 | SIRT2 779/4885NMBR 1091/4885LTA4H 1029/4885 |
| US-20240209020-A1 | REACTION AGENT FOR AMIDE REACTION AND METHOD FOR PRODUCING AMIDE COMPOUND USING SAME | NAAA, FAAH, FAAH2 | SIRT2 1041/4885NMBR 2283/4885LTA4H 158/4885 |
| US-11512108-B2 | Method for producing amide compound | BCAT2, ASNS, VIP | SIRT2 271/4885NMBR 3165/4885LTA4H 1345/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.